Cerdulatinib for treating myeloma
US-2021299125-A1 · Sep 30, 2021 · US
Portola Pharm Inc holds 90 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 90 |
| Recent patents | 0 |
| First publication | Jan 20, 2015 |
| Latest publication | Sep 30, 2021 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-2021299125-A1 · Sep 30, 2021 · US
US-11028382-B2 · Jun 8, 2021 · US
US-2021147392-A1 · May 20, 2021 · US
US-2021085762-A1 · Mar 25, 2021 · US
US-2021052582-A1 · Feb 25, 2021 · US
Representative or frequently cited publications from precomputed assignee stats.
US-2021299125-A1 · Sep 30, 2021 · US
US-11028382-B2 · Jun 8, 2021 · US
US-2021147392-A1 · May 20, 2021 · US
US-2021085762-A1 · Mar 25, 2021 · US
US-2021052582-A1 · Feb 25, 2021 · US
Most common classification codes in this portfolio.
| CPC | Patents |
|---|---|
| C12N9/6432 | 38 |
| C12Y304/21006 | 33 |
| A61K38/4846 | 32 |
| A61P7/04 | 31 |
| A61P7/02 | 30 |
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 81 |
| Chemistry & Metallurgy | 78 |
| Operations & Transport | 3 |
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.